BIOTIME INC 4

4 · BIOTIME INC · Filed Jul 23, 2014

Form 4

Period: 2014-07-21

Senior VP & COO

Transactions

Exercise/Conversion
Option to Purchase Common Shares
2014-07-21−475,000→ 0 total
Exercise: $0.50Exp: 2014-10-09→ Common Shares (475,000 underlying)
Tax Payment
Common Shares, no par value
2014-07-21$2.65/sh−89,623$237,501→ 415,777 total
Sale
Common Shares, no par value
2014-07-22$2.65/sh−100,000$265,000→ 315,777 total
Exercise/Conversion
Common Shares, no par value
2014-07-21$0.50/sh+475,000$237,500→ 505,400 total

Holdings

Option to Purchase Common Shares
Exercise: $4.22Exp: 2020-02-19→ Common Shares (100,000 underlying)
100,000
Option to Purchase Common Shares
Exercise: $3.51Exp: 2021-03-19→ Common Shares (100,000 underlying)
100,000

Footnotes (6)

[F1]Does not include shares that may be acquired upon the exercise of certain stock options.
[F2]These shares were surrendered to the company for the exercise of stock options on July 21, 2014. The options exercised were due to expire on October 9, 2014.
[F3]These shares were sold in a privately negotiated transaction to a single purchaser to obtain funds to pay taxes arising from the exercise of options on July 21, 2014.
[F4]1/60th of the number of options became exercisable at the end of each full month of employment after October 10, 2007.
[F5]1/48th of the number of options will vest and become exercisable at the end of each full month of employment after January 1, 2013.
[F6]1/48th of the number of options will vest and become exercisable at the end of each full month of employment after March 20, 2014.

Documents

1 file